Loading clinical trials...
Loading clinical trials...
Clinical Performance Evaluation of the BD OneFlow CLPD Panel (BD OneFlow LST, and B-CLPD T1 to T4 Assays) on the BD FACSLyric System.
Conditions
Interventions
BD OneFlow LST, and B-CLPD T1 to T4 Assays
Locations
6
United States
University of Norht Calolina
Chapel Hill, North Carolina, United States
CorePATH Laboratories
San Antonio, Texas, United States
Erasmus Medical Center, Laboratory Medical Immunology, Department of Immunology
Rotterdam, Netherlands
Champalimaud Foundation
Lisbon, Portugal
University of Salamanca
Salamanca, Spain
Kantonsspital Aarau AG / IfLM
Aarau, Switzerland
Start Date
October 12, 2022
Primary Completion Date
May 8, 2024
Completion Date
May 8, 2024
Last Updated
September 26, 2024
Lead Sponsor
Becton, Dickinson and Company
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions